ARCHIVES

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

This article is from The Cancer Letter archive.

Vol. 28 No. 24 | June 14, 2002

Download PDF Visit The Full Archive

Related Articles

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

April 16, 1999

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

New Therapies Could Benefit Patients With Difficult Cancers

June 25, 2010

Reduced-Fat Diet May Cut Risk Of Breast Cancer Recurrence.

December 22, 2006

Lombardi Recruits Adams-Campbell.

October 3, 2008

Copeland Named Director, UF Cancer Center

February 10, 1995